3rd Quarter - Report

NVG, LLC for PHRMA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

A bill to prohibit certain patent settlements between brand name drug companies and generic drug companies (S. 369, H.R. 1706).

LobbyistCovered position, as disclosed
ANDREA LARUE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 369 (111th), H.R. 1706 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.